Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 281 到 300 筆資料,總共 584 筆
< 上一頁
下一頁 >
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2002
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy
SUNG-HSIN KUO
; LIANG-IN LIN
; Chang C.-J.; Liu Y.-R.; Lin K.-S.; ANN-LII CHENG
Journal of Clinical Microbiology
25
20
2011
Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy
YU-YUN SHAO
; LI-CHUN LU
; ANN-LII CHENG
; CHIH-HUNG HSU
Oncologist
34
28
2011
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
Ch'Ang H.-J.; Lin Y.-L.; HSIU-PO WANG
; Chiu Y.-F.; MING-CHU CHANG
; CHIH-HUNG HSU
; YU-WEN TIEN
; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG
; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.
International Journal of Radiation Oncology Biology Physics
19
17
2009
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
CHIA-CHI LIN
; CHIH-HUNG HSU
; CHIA-HSIEN CHENG
; CHAO-YUAN HUANG
; YU-CHIEH TSAI
; Feng-Ming Hsu
; KUO-HOW HUANG
; ANN-LII CHENG
; YEONG-SHIAU PU
International Journal of Radiation Oncology Biology Physics
27
22
2009
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
DA-LIANG OU
; Ying-Chun Shen
; JA-DER LIANG
; Liou J.-Y.; SUNG-LIANG YU
; Fan H.-H.; Wang D.-S.; YEN-SHEN LU
; CHIUN HSU
; ANN-LII CHENG
Clinical Cancer Research
32
34
2010
Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
DA-LIANG OU
; Ying-Chun Shen
; SUNG-LIANG YU
; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; LIANG-IN LIN
; CHIUN HSU
; ANN-LII CHENG
Cancer Research
70
69
2002
Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin
CHIH-HUNG HSU
; Hergenhahn M.; Chuang S.-E.; Yeh P.-Y.; Wu T.-C.; Gao M.; ANN-LII CHENG
Anticancer Research
15
13
2011
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
SHIH-HUNG YANG
; Kuo Y.-H.; YU-WEN TIEN
; CHIUN HSU
; CHIH-HUNG HSU
; SUNG-HSIN KUO
; ANN-LII CHENG
Oncology
13
13
1997
Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability
MING-SHIANG WU
; JIN-CHUAN SHEU; CHIA-TUNG SHUN
; Lee W.-J.; JIN-TOWN WANG
; Wang T.-H.; ANN-LII CHENG
; Lin J.-T.
Cancer Letters
31
29
2000
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats
Chuang S.-E.; ANN-LII CHENG
; Lin J.-K.; Kuo M.-L.
Food and Chemical Toxicology
181
151
2012
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells
Chen K.-F.; Lin J.-P.; Shiau C.-W.; Tai W.-T.; Liu C.-Y.; Yu H.-C.; PEI-JER CHEN
; ANN-LII CHENG
Biochemical Pharmacology
50
50
2013
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
Yu H.-C.; Chen H.-J.; Chang Y.-L.; Liu C.-Y.; Shiau C.-W.; ANN-LII CHENG
; Chen K.-F.
Biochemical Pharmacology
45
44
1998
Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen
ANN-LII CHENG
; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH
; Liao C.-M.; Lay J.-D.; Chen D.-S.
Biochemical Pharmacology
69
65
2016
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
Lin H.-H.; Feng W.-C.; LI-CHUN LU
; YU-YUN SHAO
; CHIH-HUNG HSU
; ANN-LII CHENG
Cancer letters
37
39
2014
Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior
Huang W.-T.; SUNG-HSIN KUO
; ANN-LII CHENG
; CHUNG-WU LIN
Modern Pathology
17
15
2005
Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro
CHIH-HUNG HSU
; Gao M.; Chen C.-L.; Yeh P.-Y.; ANN-LII CHENG
Oncology
39
37
2004
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells
YEONG-SHIAU PU
; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG
; Lai M.-K.; Kuo M.-L.
Prostate
70
71
2003
Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells
Yeh P.Y.; Chuang S.-E.; KUN-HUEI YEH
; Song Y.C.; ANN-LII CHENG
Biochemical Pharmacology
37
31
2017
Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases: A nationwide database study
YI-HSIN LIANG
; YU-YUN SHAO
; Chen, Ho Min; ANN-LII CHENG
; Lai, Mei Shu; KUN-HUEI YEH
Anticancer Research
10
11
2011
IκB kinases increase Myc protein stability and enhance progression of breast cancer cells
Yeh P.-Y.; YEN-SHEN LU
; DA-LIANG OU
; ANN-LII CHENG
Molecular Cancer
24
23